Duobrii in Combination With Biologics
Recruiting · NCT04119102 · Interventional (participants receive a specific treatment) · Lead sponsor: Psoriasis Treatment Center of Central New Jersey
View the official record on ClinicalTrials.gov →Interventions studied
Duobrii
What this trial is about
12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Male or female adult ≥ 18 years of age;
- Diagnosis of chronic plaque-type
- Psoriasis affecting 2%-10% BSA
- Patient is being treated with biologic therapy for a minimum of 24 weeks
- Able and willing to give written informed consent prior to performance of any study-related procedures
Exclusion criteria
- Psoriasis affecting ˂2% or \>10% BSA
- Patient not receiving a biologic agent, or receiving biologic agent \<24weeks
- Received treatment with any topical antipsoriatic drug product within 14 days prior to the Baseline visit.
- Has previously used DUOBRII
Where it is running
1 location listed across 1 US state.
- Psoriasis Treatment Center of Central New Jersey - East Windsor, New Jersey, United States